Concordia Healthcare Corp. T.CXR.R

Read this you shorters...Nobody needs your opinion

[Kays123]

Concordia International Corp. ( 

CXRX

 ) is reporting for the quarter ending June 30, 2016. The drug company's consensus earnings per share forecast from the 2 analysts that follow the stock is $1.48. This value represents a 54.17% increase compared to the same quarter last year. The "days to cover" for this stock exceeds 51 days. Zacks Investment Research reports that the 2016 Price to Earnings ratio for CXRX is 2.60 vs. an industry ratio of -4.00, implying that they will have a higher earnings growth than their competitors in the same industry. 


Read more:  https://www.nasdaq.com/article/Thu,%2011%20Aug%202016%2016:00:03%20-0400#ixzz4H3rT0OcY